Epicore Biosystems
$31.7M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Epicore Biosystems is currently valued at $121.0M as of May 1, 2025. The company has raised a total of $43.1M in funding.
Capital Efficiency
With a capital efficiency ratio of 2.81x, Epicore Biosystems has achieved a valuation that is 2.81 times the total capital raised. This metric indicates moderate capital efficiency.
Investment Perspective
Epicore Biosystems's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Epicore Biosystems Worth in 2025?
As of 2025, Epicore Biosystems is valued at $121.0M, based on the company's Later Stage VC funding round in May 1, 2025. This valuation positions Epicore Biosystems as one of the leading private companies in the sector.
Epicore Biosystems Valuation History
Epicore Biosystems's funding history demonstrates steady growth and investor confidence.
How Epicore Biosystems Valuation is Determined
Private company valuations like Epicore Biosystems's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Epicore Biosystems Valuation FAQs
Is Epicore Biosystems profitable?
Epicore Biosystems has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Epicore Biosystems's valuation compare to competitors?
Epicore Biosystems is valued at $121.0M, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Epicore Biosystems IPO?
Epicore Biosystems has not announced plans for an initial public offering. Until an IPO, investors can access Epicore Biosystems shares through secondary market platforms.